Literature DB >> 15128284

Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal.

Sinead N Kelly1, T Joseph McKenna, Leonie S Young.   

Abstract

The capacity of the adrenal to produce cortisol is controlled in part by 21-hydroxylase (CYP21) and the production of androgens by 17-hydroxylase/17-20-lyase (CYP17), in response to secretagogues including ACTH, angiotensin-II (A-II) and insulin. In this study we examined the capacity of human adrenocortical cells to produce cortisol and androgens in response to these secretagogues and their ability to regulate the expression of CYP21 and CYP17. In H-295 cells, forskolin and A-II were found to stimulate production of cortisol relative to androstenedione and a similar pattern of steroid production was noted in primary human adrenocortical cells. Both mRNA and protein expression of CYP21 was upregulated with forskolin and A-II alone and in combination, as detected by Northern and Western blotting. Whereas expression of CYP17 mRNA and protein was up regulated in the presence of forskolin and forskolin in combination with insulin. The ability of steroidogenic factor-1 (SF-1) and nur77 to regulate transcription of these enzymes was examined. Forskolin, A-II and insulin increased the protein expression of SF-1. Increased binding of SF-1 to its response element in the presence of forskolin, A-II and insulin was observed. Nur77 was expressed primarily in the zona glomerulosa and fasciculata. Increased protein expression of nur77 and the greatest binding of nur77 to its response element was seen when cells were stimulated with A-II in combination with forskolin. These data indicate that nur77 may preferentially regulate steroid enzyme genes relevant to cortisol production and thereby regulate differential cortisol and adrenal androgen production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128284     DOI: 10.1677/joe.0.1810355

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  17 in total

1.  Growth Hormone-induced STAT5B Regulates Star Gene Expression Through a Cooperation With cJUN in Mouse MA-10 Leydig Cells.

Authors:  Pierre-Olivier Hébert-Mercier; Francis Bergeron; Nicholas M Robert; Samir Mehanovic; Kenley Joule Pierre; Raifish E Mendoza-Villarroel; Karine de Mattos; Catherine Brousseau; Jacques J Tremblay
Journal:  Endocrinology       Date:  2022-02-01       Impact factor: 4.736

Review 2.  Angiotensin II regulation of adrenocortical gene transcription.

Authors:  Edson F Nogueira; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2008-09-03       Impact factor: 4.102

3.  Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line.

Authors:  Ashim Kumar; Denis Magoffin; Iqbal Munir; Ricardo Azziz
Journal:  Fertil Steril       Date:  2008-08-05       Impact factor: 7.329

4.  The orphan nuclear receptor NUR77 regulates hormone-induced StAR transcription in Leydig cells through cooperation with Ca2+/calmodulin-dependent protein kinase I.

Authors:  Luc J Martin; Nicolas Boucher; Catherine Brousseau; Jacques J Tremblay
Journal:  Mol Endocrinol       Date:  2008-07-03

5.  Regulation of P450c17 expression in the early embryo depends on GATA factors.

Authors:  Yimin Shi; Marcus D Schonemann; Synthia H Mellon
Journal:  Endocrinology       Date:  2008-10-01       Impact factor: 4.736

6.  SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation.

Authors:  Wei-Hsiung Yang; Joanne H Heaton; Holly Brevig; Sarmistha Mukherjee; Jorge A Iñiguez-Lluhí; Gary D Hammer
Journal:  Mol Cell Biol       Date:  2008-11-17       Impact factor: 4.272

7.  Androstenedione up-regulation of endometrial aromatase expression via local conversion to estrogen: potential relevance to the pathogenesis of endometriosis.

Authors:  Orhan Bukulmez; Daniel B Hardy; Bruce R Carr; Richard J Auchus; Tannaz Toloubeydokhti; R Ann Word; Carole R Mendelson
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

8.  Roux-en-Y gastric bypass in the treatment of non-classic congenital adrenal hyperplasia due to 11-hydroxylase deficiency.

Authors:  Amir Kalani; Nithin Thomas; Alan Sacerdote; Gül Bahtiyar
Journal:  BMJ Case Rep       Date:  2013-03-18

9.  Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans.

Authors:  Christoph Koentges; Mark E Pepin; Carolyn Müsse; Katharina Pfeil; Sonia V Viteri Alvarez; Natalie Hoppe; Michael M Hoffmann; Katja E Odening; Samuel Sossalla; Andreas Zirlik; Lutz Hein; Christoph Bode; Adam R Wende; Heiko Bugger
Journal:  Basic Res Cardiol       Date:  2017-12-29       Impact factor: 17.165

Review 10.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.